Advisor Group’s Windtree Therapeutics Inc WINT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-130
Closed 5055
2017
Q1
$0 Hold
130
﹤0.01% 4920
2016
Q4
$0 Hold
130
﹤0.01% 4764
2016
Q3
$0 Hold
130
﹤0.01% 4752
2016
Q2
$0 Buy
+130
New +$314 ﹤0.01% 4626

Other funds holding WINT

Advisor Group's WINT Position: Q2 2017 in Review

Advisor Group sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 130 shares.

Advisor Group first reported a position in WINT in Q2 2016 and held it in 4 quarters. The position peaked at $0 in Q1 2017. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Advisor Group reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Advisor Group sold 130 Windtree Therapeutics Inc shares in Q2 2017.
  • Advisor Group first reported a position in Windtree Therapeutics Inc in Q2 2016 and held it in 4 quarters.
  • Advisor Group's Windtree Therapeutics Inc position peaked at $0 in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Advisor Group's 13F filing for Q2 2017, filed 11 Aug 2017.